The vaccine goal

in page functions

Accelerate the uptake and use of underused and new vaccines by strengthening country decision-making and introduction

Vaccine goal

By the end of the 2011–2015 period, all Gavi-supported countries had introduced the pentavalent vaccine. We also helped accelerate access to new vaccines, in particular pneumococcal and rotavirus vaccines, which protect against the main causes of pneumonia and deadly diarrhoea.

Country introduction targets for pentavalent, pneumococcal and rotavirus vaccines were reached more than one year ahead of schedule.

We also started supporting several new vaccines in this period, including those protecting against human papillomavirus (HPV), rubella, Japanese encephalitis and polio.

More than 200 vaccine introductions

We supported more than 200 vaccine introductions and campaigns in the 2011–2015 period – four times as many as in the previous five years.

Goal-level indicators

Strategic objectives


US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here